Skip to main content
. 2024 Dec 19;7:1673. doi: 10.1038/s42003-024-07364-2

Fig. 3. In vitro immunomodulatory potential of EVs, assessed by mixed lymphocyte reaction.

Fig. 3

Lymphocytes from SD /CD and Wistar rat strains were mixed, stimulated for 48 h with PHA-M and ConA, then treated with rat ADSC EVs at a dose ranging from 0 (negative control) to 7.0.1010 particles per well. Lymphocyte proliferation rates were assessed at 24 h and normalized to the proliferation rate observed in the negative control group. Data are shown as the mean ± SD with individual values (6 biological replicates from 2 independent experiments per group).